ren001
Cell therapyexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
2
Phase 4
0
Earliest trial started Apr 4, 2019 (NCT03833128)
Timeline
Indications
Mechanism of action
- NeuronsTissue restoration
Neurons tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05267574 | Phase 2/Phase 3 (Phase 3) | Feb 1, 2022 | Reneo Pharma Ltd |
| NCT04535609 | Phase 2/Phase 3 (Phase 3) | Feb 28, 2021 | Reneo Pharma Ltd |
| NCT04226274 | Phase 1 | Dec 10, 2019 | Reneo Pharma Ltd, University of London |
| NCT03862846 | Phase 1 | May 10, 2019 | Newcastle University, Reneo Pharma Ltd |
| NCT03833128 | Phase 1 | Apr 4, 2019 | Reneo Pharma Ltd, University of Pittsburgh |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Reneo Pharma Ltd | For profit | 5 | 5 | 2 | 2019 |
| Newcastle University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2019 |
4 organizations
Page 1 / 1